Pharmacia and Upjohn Company LLC (secondary packaging, labeling, storage, batch release)

The drug is used for the treatment of newly diagnosed CD33-positive acute myeloid leukemia in adults and children (from 1 month of age), as well as for the treatment of relapsed or refractory CD33-positive acute myeloid leukemia in adults and children (from 2 years of age).

Dosage form: powder for concentrate for infusion solution

ATC: L01XC05